Insider · CIK 0001405692

Collins Cynthia

Reports to the SEC for 8 companies · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001405692

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-17	CDXSCODEXIS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+66.4K sh	—	—	66,350
2026-06-17	MXCTMAXCYTE, INC. · Stock Option (right to buy)A Award	Director	AAward	+49.6K sh	—	—	49,579
2026-06-17	MXCTMAXCYTE, INC.A Award	Director	AAward	+30.4K sh	—	—	111,310
2026-05-14	CERTCertara, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+15.8K sh	—	—	51,846
2026-05-14	CERTCertara, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−15.8K sh	—	—	0
2025-06-18	MXCTMAXCYTE, INC.A Award	Director	AAward	+29.2K sh	—	—	80,889
2025-06-18	MXCTMAXCYTE, INC. · Stock Option (right to buy)A Award	Director	AAward	+50.8K sh	—	—	50,790
2025-06-10	CDXSCODEXIS, INC.A Award	Director	AAward	+41K sh	—	—	112,157
2025-05-21	CERTCertara, Inc. · Restricted Stock UnitsA Award	Director	AAward	+15.8K sh	—	—	15,757
2025-05-21	CERTCertara, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−11.9K sh	—	—	0
2025-05-21	CERTCertara, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+11.9K sh	—	—	36,089
2025-03-28	CDXSCODEXIS, INC.A Award	Director	AAward	+71.2K sh	—	—	71,174
2025-01-08	Poseida Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−28.5K sh	—	—	0
2025-01-08	Poseida Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−27.4K sh	—	—	0
2025-01-08	Poseida Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−87.4K sh	—	—	0
2025-01-08	Poseida Therapeutics, Inc.U Disposition from Tender	Director	UDisposition from Tender	−59K sh	—	—	0
2025-01-08	Poseida Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−27.4K sh	—	—	0
2024-10-14	MXCTMAXCYTE, INC. · Stock Option (right to buy)A Award	Director	AAward	+97.7K sh	—	—	97,698
2024-10-14	MXCTMAXCYTE, INC.A Award	Director	AAward	+51.7K sh	—	—	51,679
2024-06-17	Poseida Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+27.4K sh	—	—	27,350
2024-06-17	Poseida Therapeutics, Inc.A Award	Director	AAward	+19.7K sh	—	—	58,950
2024-05-21	CERTCertara, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+8,663 sh	—	—	24,161
2024-05-21	CERTCertara, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−8,663 sh	—	—	0
2024-05-21	CERTCertara, Inc. · Restricted Stock UnitsA Award	Director	AAward	+11.9K sh	—	—	11,928
2023-06-15	Poseida Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+27.4K sh	—	—	27,350
2023-06-15	Poseida Therapeutics, Inc.A Award	Director	AAward	+19.7K sh	—	—	39,300
2023-06-01	DermTech, Inc.A Award	Director	AAward	+35.7K sh	—	—	104,835
2023-05-23	CERTCertara, Inc. · Restricted Stock UnitsA Award	Director	AAward	+8,663 sh	—	—	8,663
2023-05-17	CERTCertara, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−9,067 sh	—	—	0
2023-05-17	CERTCertara, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,067 sh	—	—	15,498
2022-06-16	Poseida Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+28.5K sh	—	—	28,500
2022-06-16	Poseida Therapeutics, Inc.A Award	Director	AAward	+19.7K sh	—	—	19,650
2022-05-26	DermTech, Inc.A Award	Director	AAward	+26.5K sh	—	—	69,121
2022-05-17	CERTCertara, Inc. · Restricted Stock UnitsA Award	Director	AAward	+9,067 sh	—	—	9,067
2021-08-01	CERTCertara, Inc.A Award	Director	AAward	+6,431 sh	—	—	6,431
2021-07-23	Poseida Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+87.4K sh	—	—	87,440
2021-05-26	DermTech, Inc.A Award	Director	AAward	+4,497 sh	—	—	37,980
2021-05-26	DermTech, Inc.A Award	Director	AAward	+4,661 sh	—	—	42,641
2021-02-09	EDITEditas Medicine, Inc.S Sale	CEO	SSale	−1,262 sh	$66.65	−$84.1K	43,760
2020-08-20	EDITEditas Medicine, Inc.S Sale	CEO	SSale	−1,976 sh	$36.66	−$72.4K	45,022
2020-06-17	DermTech, Inc.A Award	Director	AAward	+8,000 sh	—	—	33,483
2020-02-06	EDITEditas Medicine, Inc. · Stock Option (right to buy)A Award	CEO	AAward	+93.8K sh	—	—	93,750
2020-02-06	EDITEditas Medicine, Inc.A Award	CEO	AAward	+15.6K sh	—	—	46,998
2020-01-30	DermTech, Inc.A Award	Director	AAward	+6,000 sh	—	—	25,483
2019-12-31	DermTech, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−8,755 sh	—	—	0
2019-12-31	DermTech, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+8,755 sh	—	—	19,483
2019-09-11	EDITEditas Medicine, Inc.A Award	CEO	AAward	+20K sh	—	—	31,373
2019-09-11	EDITEditas Medicine, Inc. · Stock Option (right to buy)A Award	CEO	AAward	+250K sh	—	—	250,000
2019-09-11	EDITEditas Medicine, Inc. · Stock Option (right to buy)A Award	CEO	AAward	+500K sh	—	—	500,000
2019-08-19	EDITEditas Medicine, Inc.A Award	CEO	AAward	+8,283 sh	—	—	16,566

Recent filings

Accepted (ET)
Jun 224
Collins Cynthia0000905148-26-003052
SEC(opens sec.gov)
Jun 184
Collins Cynthia0001610717-26-000272
SEC(opens sec.gov)
May 154
Collins Cynthia0001405692-26-000002
SEC(opens sec.gov)
Jun 234
Collins Cynthia0000905148-25-002231
SEC(opens sec.gov)
Jun 124
Collins Cynthia0000905148-25-002128
SEC(opens sec.gov)
May 224
Collins Cynthia0001415889-25-014189
SEC(opens sec.gov)
Apr 14
Collins Cynthia0000905148-25-001032
SEC(opens sec.gov)
Jan 84
Collins Cynthia0001415889-25-001086
SEC(opens sec.gov)
Oct 164
Collins Cynthia0000905148-24-002726
SEC(opens sec.gov)
Jun 184
Collins Cynthia0000950170-24-074865
SEC(opens sec.gov)

Companies

Address

C/O MAXCYTE, INC. 9713 KEY WEST AVENUE, SUITE 400

ROCKVILLE, MD, 20850